Overall Technical outlook

Price Summary

On 2026-07-01, JUBLPHARMA's stock started at 976.0, reached a high of 999.75, fell to 962.7, and ended -0.01% down at 975.9, with 90468 shares traded.
The stock reached its highest price of 1236.3 and lowest price of 807.65 over the last 52 weeks.

Technicals

Support and Resistance: At 975.9, the price is supported at 945.4 and faces resistance at 981.9. This range suggests that the price for JUBLPHARMA might stay between these levels, with 945.4 acting as a floor and 981.9 as a ceiling.
JUBLPHARMA supportResistance 69465f
Support/Resistance for JUBLPHARMA


Aroon: The AROON is in a neutral stance for JUBLPHARMA, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
JUBLPHARMA aroon 69465f
Aroon chart for Jubilant Pharmova Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
JUBLPHARMA bbands 69465f
Bolinger Bands chart for Jubilant Pharmova Limited


Parabolic SAR: The PSAR maintains its bullish stance, setting a significant support level that could help maintain the market's upward movement. This strong support suggests that the market is poised to continue its positive trend, providing confidence in the ongoing bullish momentum.
JUBLPHARMA psar 69465f
Parabolic Stop and Reverse chart for Jubilant Pharmova Limited


Stochastic: The STOCHASTIC is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
JUBLPHARMA stoch 69465f
Stochastic chart for Jubilant Pharmova Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
JUBLPHARMA trippleSMA 69465f
Tripple SMA chart for Jubilant Pharmova Limited


A comprehensive approach to analyzing a company requires considering both its technical and fundamental aspects. The company's fundamentals, such as its earnings, growth prospects, and financial health, provide a strong foundation for understanding technical indicators. Additionally, examining the industry it operates in helps contextualize the company's position within the broader market. By integrating these factors, one can gain more valuable insights into the company's stock performance and potential investment opportunities.